STOCK TITAN

Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Zymergen Inc. will report preliminary financial results for Q4 and full year 2021 on March 22, 2022, after market close. The company's management will hold a conference call at 1:30 PM PT to discuss these results and future outlook. Zymergen focuses on creating molecules and materials through biotechnology, aiming to improve product offerings across various markets.

Positive
  • Company scheduled to report preliminary financial results, indicating active financial management.
  • Expectations for a conference call signal transparency and communication with investors.
Negative
  • None.

EMERYVILLE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022. The company’s management will host a conference call beginning at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss its results, business developments and outlook.

A webcast of the conference call can be accessed at https://investors.zymergen.com/.

About Zymergen

Zymergen is a biotech company that designs and produces molecules, microbes and materials for diverse end markets. We partner with nature to make better products, a better way, for a better world.

Investor Contact
Carrie Mendivil
investors@zymergen.com

Media Contact
Mike Dulin
mdulin@zymergen.com


FAQ

When will Zymergen report its Q4 2021 financial results?

Zymergen will report its preliminary financial results for Q4 2021 on March 22, 2022.

What time is Zymergen's conference call?

Zymergen's conference call is scheduled for 1:30 PM Pacific Time on March 22, 2022.

How can I access the Zymergen conference call?

The conference call can be accessed through Zymergen's investor relations page.

What is Zymergen's business focus?

Zymergen specializes in designing and producing molecules and materials for various markets.

ZY

NASDAQ:ZY

ZY Rankings

ZY Latest News

ZY Stock Data

253.58M
96.93M
6.27%
65.09%
3.6%
Specialty Chemicals
Basic Materials
Link
United States
EmeryVille